CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Left Ventricular Assist Devices: Synergistic Model Between Technology and Medicine Therapeutic Options for In-Stent Restenosis Aggressive lipid-lowering therapy after percutaneous coronary intervention – for whom and how? SGLT2 Inhibitors in Patients With Heart Failure With Reduced Ejection Fraction: A Meta-Analysis of the EMPEROR-Reduced and DAPA-HF Trials Sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: A Phase IIb, randomised, double-blind, placebo-controlled study - Rationale and study design Ticagrelor with or without Aspirin in High-Risk Patients after PCI Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis: 1-Year Results From the All-Comers NOTION Randomized Clinical Trial Rationale and design of the GUIDE-IT study: Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure Impact of Optimized Procedure-Related Factors in Drug-Eluting Balloon Angioplasty for Treatment of In-Stent Restenosis
|<<... 68 69 70 71 72 73 74 ...>>|

Review Article2018;138:2841–2851

JOURNAL：Circulation. Article Link

Left Ventricular Assist Devices: Synergistic Model Between Technology and Medicine

JJ Han, MA Acker, P Atluri et al. Keywords: left ventricular assist device; heart failure; suck-down event; park stitch; HMIII artificial pulsatility; hemocompatability; quality-adjusted life years; incremental cost-effectiveness ratio

FULL TEXT PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top